drugset / Trial / NCT00637481

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

NCT00637481

Phase 1 Completed 66 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupOpen-labelPrevention

Summary

Chemoprevention is the use of certain drugs to keep cancer from forming. The use of atorvastatin (Lipitor) may prevent breast cancer. This randomized phase I trial is studying the best dose of atorvastatin in preventing breast cancer in women at increased risk for breast cancer.

Timeline

Start
2008-03
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule Oral